X-47447911-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001324144.2(ZNF41):c.1859C>T(p.Ser620Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000339 in 1,209,904 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000072 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000030 ( 0 hom. 11 hem. )
Consequence
ZNF41
NM_001324144.2 missense
NM_001324144.2 missense
Scores
1
4
9
Clinical Significance
Conservation
PhyloP100: 0.307
Genes affected
ZNF41 (HGNC:13107): (zinc finger protein 41) This gene encodes a protein that contains KRAB-A and KRAB-B domains multiple zinc finger DNA binding motifs and finger linking regions characteristic of the Kruppel family. An initial study suggested that this gene may be associated with X-linked cognitive disability, but a later study has called this finding into question (PMID:23871722).[provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.018694073).
BS2
High Hemizygotes in GnomAdExome4 at 11 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF41 | NM_001324144.2 | c.1859C>T | p.Ser620Leu | missense_variant | 5/5 | ENST00000684689.1 | NP_001311073.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF41 | ENST00000684689.1 | c.1859C>T | p.Ser620Leu | missense_variant | 5/5 | NM_001324144.2 | ENSP00000508254 | P1 | ||
ZNF41 | ENST00000313116.11 | c.1859C>T | p.Ser620Leu | missense_variant | 5/5 | 1 | ENSP00000315173 | P1 | ||
ZNF41 | ENST00000377065.8 | c.1859C>T | p.Ser620Leu | missense_variant | 5/5 | 1 | ENSP00000366265 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000716 AC: 8AN: 111672Hom.: 0 Cov.: 23 AF XY: 0.0000295 AC XY: 1AN XY: 33866
GnomAD3 genomes
AF:
AC:
8
AN:
111672
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
33866
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000185 AC: 34AN: 183417Hom.: 0 AF XY: 0.000162 AC XY: 11AN XY: 67867
GnomAD3 exomes
AF:
AC:
34
AN:
183417
Hom.:
AF XY:
AC XY:
11
AN XY:
67867
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000300 AC: 33AN: 1098232Hom.: 0 Cov.: 32 AF XY: 0.0000303 AC XY: 11AN XY: 363592
GnomAD4 exome
AF:
AC:
33
AN:
1098232
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
363592
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000716 AC: 8AN: 111672Hom.: 0 Cov.: 23 AF XY: 0.0000295 AC XY: 1AN XY: 33866
GnomAD4 genome
AF:
AC:
8
AN:
111672
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
33866
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
18
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2023 | The c.1859C>T (p.S620L) alteration is located in exon 5 (coding exon 4) of the ZNF41 gene. This alteration results from a C to T substitution at nucleotide position 1859, causing the serine (S) at amino acid position 620 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;T
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationTaster
Benign
N;N;N
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MVP
MPC
0.83
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at